Long | 合法藥品大搜索
由KYokoyama著作·2019·被引用15次—Evocalcetisanovelcalcimimeticdevelopedasanequallyefficacious,butmoretolerable,alternativetothecurrentlyavailable ...
Patient backgroundWritten informed consent was obtained from 152 Japanese HD patients with SHPT. Of these, 15 were judged to be ineligible for enrollment, and a total of 137 patients were enrolled in the present study to receive oral administration of evocalcet (Fig. 1B). The demographics of the enrolled patients are presented in Table 1. Of the 137 patients, 81 were male and 56 were female with a mean (SD) age of 60.3 (10.3) years. Of the 137 patients enrolled, 24 patients (17.5%) discontinued treatment and 113 patients (82.5%) completed the study up to week 52 (Fig. 1B). Of the 137 patients participating, evocalcet was taken as prescribed each day (adherence rate) 99.1 ± 2.2% of the time.
Table 1 Patient characteristics at baseline (n = 137).Of the 137 patients, 113 patients had the following cinacalcet treatment on the day before be...
Evocalcet: A New Oral Calcimimetic for Dialysis ... | 合法藥品大搜索
Pharmacodynamics of evocalcet for secondary ... | 合法藥品大搜索
Evocalcet | 合法藥品大搜索
Head | 合法藥品大搜索
Long | 合法藥品大搜索
Long | 合法藥品大搜索
Evocalcet | 合法藥品大搜索
Evocalcet | 合法藥品大搜索
Evocalcet | 合法藥品大搜索
Pharmacokinetics of evocalcet in secondary ... | 合法藥品大搜索
【銳克鈣錠75毫克】治療透析患者的次發性副甲狀腺機能亢進。
藥品名稱:銳克鈣錠75毫克許可證字號:衛署藥輸字第025140號許可證種類:製 劑適應症:治療透析患者的次發性副甲狀腺機能亢進。...
【福祿鈣片】缺鈣、齲齒
藥品名稱:福祿鈣片許可證字號:內衛藥製字第008220號許可證種類:製 劑適應症:缺鈣、齲齒劑型:藥品類別:醫師藥師藥劑生指示藥...
【鈣易清膜衣錠25毫克】治療透析患者的次發性副甲狀腺機能亢進。
藥品名稱:鈣易清膜衣錠25毫克許可證字號:衛部藥製字第058545號許可證種類:製 劑適應症:治療透析患者的次發性副甲狀腺機能亢...
【旁必福注射液】PARSABIV適用於治療罹患慢性腎臟病 (CKD) 且接受血液透析之成人病人的次發性副甲狀腺機能亢進 (secondary HPT)。
藥品名稱:旁必福注射液許可證字號:衛部藥輸字第027639號許可證種類:製 劑適應症:PARSABIV適用於治療罹患慢性腎臟病(CKD)且...
【銳克鈣錠25毫克】治療透析患者的次發性副甲狀腺機能亢進。
藥品名稱:銳克鈣錠25毫克許可證字號:衛署藥輸字第025141號許可證種類:製 劑適應症:治療透析患者的次發性副甲狀腺機能亢進。...